-- First of two Pivotal Efficacy Studies support future sNDA submission for Treatment of Pulmonary Anthrax -- Oral NUZYRA Tablets Produced in the U.S. as a Result of the Company's Onshoring Initiative ...

First of two Pivotal Efficacy Studies support future sNDA submission for Treatment of Pulmonary AnthraxOral NUZYRA Tablets Produced in the U.S.

Anthrax is an infectious disease caused by the bacterium Bacillus anthracis. While the infection is often treatable in its early stages, once the disease has progressed beyond the “point of no return” ...

Vision – To be the world's leading and most trusted provider of information and services that will make a real difference in clinical practice and improve outcomes for patients. Mission – To lead the ...

Several animals have been found dead due to infection by anthrax in Wyoming. The Wyoming Game and Fish Department announced on September 3 that a dead moose had tested positive for anthrax in Carbon ...

Bacillus anthracis lethal toxin (LT) is a determinant of lethal anthrax. Its function in myeloid cells is required for bacterial dissemination, and LT itself can directly trigger dysfunction of the ...

Four patients infected with anthrax in Tuva, a region in Russia's southern Siberia, have escaped from the hospital where they were being treated, according to the regional Ministry of Health. "Four ...

BOSTON, July 10, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving ...

Researchers have taken a step toward the development of a therapeutic that can treat infection of antibiotic-resistant strains of anthrax in mice without antibiotics. A new therapy against ...